Deletions of the derivative chromosome 9 do not influence the response and the outcome of chronic myeloid leukemia in early chronic phase treated with imatinib mesylate: GIMEMA CML Working Party analysis.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples